The NHS Long Term Plan will integrate mental and physical health services in hospitals through the further development of liaison mental health teams in acute hospitals\u2019 emergency departments and inpatient wards. A programme is already in place to deliver the commitment set out in the Five Year Forward View that by 2020/21 all acute hospitals will have liaison teams in place, with at least half to provide this on a 24 hours a day, seven days a week basis in line with the \u2018Core 24\u2019 standard established by the Royal College of Psychiatrists. Under the NHS Long Term Plan, by 2023/24, 70% of these liaison services will meet the \u2018Core 24\u2019 service standard.<\/p>
<\/p>
On the future funding of services, the NHS Long Term Plan National Implementation Framework, to be published in the spring, will provide further information on how the NHS Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed National Implementation Plan in the autumn.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2019-02-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "220898"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-20T11:53:19.82Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure closer integration of mental and physical health services within hospitals as part of the NHS Long Term Plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "220897"} , {"_about" : "http://data.parliament.uk/resources/1060857", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060857/answer", "answerText" : {"_value" : "
The NHS Long Term Plan will integrate mental and physical health services in hospitals through the further development of liaison mental health teams in acute hospitals\u2019 emergency departments and inpatient wards. A programme is already in place to deliver the commitment set out in the Five Year Forward View that by 2020/21 all acute hospitals will have liaison teams in place, with at least half to provide this on a 24 hours a day, seven days a week basis in line with the \u2018Core 24\u2019 standard established by the Royal College of Psychiatrists. Under the NHS Long Term Plan, by 2023/24, 70% of these liaison services will meet the \u2018Core 24\u2019 service standard.<\/p>
<\/p>
On the future funding of services, the NHS Long Term Plan National Implementation Framework, to be published in the spring, will provide further information on how the NHS Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed National Implementation Plan in the autumn.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2019-02-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "220897"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-20T11:53:19.867Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what proportion of new funding under the NHS Long Term Plan is being assigned to support closer integration of mental and physical health services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "220898"} , {"_about" : "http://data.parliament.uk/resources/1060858", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060858/answer", "answerText" : {"_value" : "
The Five Year Forward View for Mental Health set out plans for expanding Improving Access to Psychological Therapies (IAPT) services so that they can treat people with long-term health conditions, such as diabetes or cardiovascular disease. This work is underway, with many integrated IAPT services providing physical care and psychological therapies.<\/p>
<\/p>
Under the NHS Long Term Plan, by 2023/24, an additional 380,000 adults and older adults will be able to access National Institute for Health and Care Excellence-approved IAPT services.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2019-02-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-20T16:43:49.42Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the NHS is taking to ensure adequate provision is made to treat mental health issues that may arise as a result of physical health conditions during the course of treatment for those conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "220899"} , {"_about" : "http://data.parliament.uk/resources/937860", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/937860/answer", "answerText" : {"_value" : "
No such assessment has been made. The General Data Protection Regulation (GDPR) is not the correct route for such requests. The right of access under GDPR confers more personal information than is needed or is justified for insurance underwriting. Accordingly, insurance companies should instead use the established mechanism of the Access to Medical Reports Act 1988 (AMRA) to obtain summary medical reports from general practitioner (GPs). The AMRA allows the GP to charge a reasonable fee to cover the cost of copying the report.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-07-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-07-18T16:37:24.727Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Data Protection"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the costs incurred to the NHS from third-parties making subject access requests under General Data Protection Regulation instead of using the Access to Medical Reports Act 1988.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "162545"} , {"_about" : "http://data.parliament.uk/resources/922333", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/922333/answer", "answerText" : {"_value" : "
The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.<\/p>
<\/p>
While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.<\/p>
<\/p>
Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-06-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "152756"} , {"_value" : "152757"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-06-20T16:03:25.817Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-06-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Packaging"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increased uniformity of medication packaging across manufacturers to enable the efficient identification of all medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "152755"} , {"_about" : "http://data.parliament.uk/resources/922337", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/922337/answer", "answerText" : {"_value" : "
The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.<\/p>
<\/p>
While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.<\/p>
<\/p>
Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-06-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "152755"} , {"_value" : "152757"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-06-20T16:03:25.88Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-06-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Packaging"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what representations he has received on the desirability of increased uniformity of medication packaging across manufacturers from the (a) public and (b) health service.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "152756"} , {"_about" : "http://data.parliament.uk/resources/922344", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/922344/answer", "answerText" : {"_value" : "
The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.<\/p>
<\/p>
While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.<\/p>
<\/p>
Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-06-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "152755"} , {"_value" : "152756"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-06-20T16:03:25.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-06-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Packaging"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the implications for the safety of patients of the variety in packaging of the same medicines; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "152757"} , {"_about" : "http://data.parliament.uk/resources/886331", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/886331/answer", "answerText" : {"_value" : "
The Government recognises that early intervention is absolutely vital and is committed to ensuring everyone with an eating disorder has access to timely treatment.<\/p>
<\/p>
For children and young people, the Government set up the first waiting times to improve access to eating disorders services for children and young people - so that by 2020/21 95% of children with an eating disorder will receive treatment within one week for urgent cases and within four weeks for routine cases. Latest figures indicate that the National Health Service is on track to meet that standard with almost 76.9% of all patients starting urgent treatment within one week and 83.1% of patients starting routine treatment within four weeks (third quarter of 2017-2018). The data is available at the following link:<\/p>
<\/p>